期刊文献+

糖尿病脑病的药物治疗 被引量:3

The pharmacotherapy of diabetic encephalopathy
原文传递
导出
摘要 越来越多的研究表明长期高糖状态可引起中枢神经系统损害,进而引起认知功能障碍,发展为糖尿病脑病。糖尿病脑病是一种以认知功能障碍以及学习和记忆能力下降为主要临床表现的慢性进行性疾病,其发病机制及治疗方法目前虽不清楚,但无疑已成为研究的热点。目前用于糖尿病脑病治疗的药物主要有作用于血管的药物、作用于G蛋白耦联受体的药物、抗氧化药物等。 An increasing number of researches indicate that long-term hyperglycemia can damage the central nervous system and cause cognitive dysfunction, then develop into diabetes encephalopathy. Diabetic encephalopathy is characterized by cognitive dysfunction and failure of learning and memory. Although its pathogenic mechanism is not clear,diabetic encephalopathy has already become a hot topic today. The pharmacotherapy of diabetes encephalopathy includes vasoactive drugs, agents acting on G-protein coupled receptors, antioxidant drugs and some other medicines.
作者 杜慧敏 肖谦
出处 《国际内分泌代谢杂志》 北大核心 2012年第2期87-90,共4页 International Journal of Endocrinology and Metabolism
基金 基金项目:国家自然科学基金资助项目(81170752) 重庆市自然科学基金资助项目(2010BB5396) 重庆市卫生局科技重点资助项目(2010-1-8) 重庆医科大学科研基金资助项目(2007018)
关键词 糖尿病脑病 认知障碍 药物治疗 Diabetic encephalopathy Cognitive dysfunction Pharmacotherapy
  • 相关文献

参考文献29

  • 1Profenno LA, Porsteinsson AP, Faraone SV. Meta-analysis of Alzhe- imer's disease risk with obesity, diabetes, and related disorders. Biol Psychiatry ,2010,67:505-512.
  • 2高原,肖谦,赵柯湘,高爱滨,吴绮楠,李龙英,张海娜.尼莫地平对糖尿病大鼠模型认知功能的保护作用[J].中国老年学杂志,2007,27(18):1753-1755. 被引量:3
  • 3Alkhenizan AH, Alswes MA. The role of renin blockers in the pre- vention of diabetes. Saudi Med J,2007,28:91-95.
  • 4张海娜,高原,赵柯湘,肖谦.替米沙坦对糖尿病大鼠学习记忆及海马Ghrelin受体表达的影响[J].中国医院药学杂志,2008,28(21):1832-1835. 被引量:3
  • 5Hutchinson DS, Summers R J, Bengtsson T. Regulation of AMP- activated protein kinase activity by G-protein coupled receptors: potential utility in treatment of diabetes and heart disease. Pharmacol Ther,2008 ,119 :291-310.
  • 6Kimura R, Okouchi M, Fujioka H, et al. Glucagon-like peptide-1 ( GLP-I ) protects against methylglyoxal-induced PC12 cell apop- tosis through the PI3K/Akt/mTOR/GCLc/redox signaling path- way. Neuroscience ,2009,162 : 1212-1219.
  • 7Rodbard HW, Jellinger PS, Davidson JA, et al. Statement by an American Association of Clinical Endocrinologists/American Col- lege of Endocrinology consensus panel on type 2 diabetes melli- tus:an algorithm for glycemic control. Endocr Pract, 2009,15: 540-559.
  • 8Nathan DM, Buse JB, Davidson MB, et al. Medical management of hyperglycemia in type 2 diabetes : a consensus algorithm for the initiation and adjustment of therapy:a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care,2009,32 : 193-203.
  • 9Rossi MC, Nicolucci A. Liraglutide in type 2 diabetes : from phar- macological development to clinical practice. Acta Biomed ,2009, 80:93-101.
  • 10Wang XH, Li L, Hslscher C, et al. Val8-glucagon-like peptide-1 protects against AI31-40-induced impairment of hippocampal late- phase long-term potentiation and spatial learning in rats. Neuroscience,2010,170:1239-1248.

二级参考文献40

  • 1Poykko SM,Kellokoski E,Horkko S,etal. Low plasma Ghrelin isassociated with insulin resistance, hypertension, and the prevalence of type 2 diabetes[J].Diabetes,2003,52(10):2546- 2553.
  • 2Irako T, Akamizu T, Hosoda H, et al. Ghrelin prevents development of diabetes at adult age in streptozotoein-treated newborn rats[J]. Diabetologia, 2006,49 (6) : 1264-1273.
  • 3Diano S, Farr SA, Benoit SC, et al. Ghrelin controls hippocampal spine synapse density and memory performance [J]. Nat Neurosci, 2006,9 (3) : 381-388.
  • 4Grillo CA, Piroli GG, Wood GE, et al. Immunocytochemical analysis of synaptic proteins provides new insights into diabetesmediated plasticity in the rat hippocampus[J]. Neuroscience, 2005,136(2):477-486.
  • 5Wright JW, Reichert JR, Davis C J, et al. Neural plasticity and the brain rennin-angiotensin system [J]. Neurosci Biobehav Rev,201)2,6(5) :529-552.
  • 6Fogari R, Mugellini A, Zoppi A, et al. Effect of telmisartan hydrochlorothiazide vs lisinopril/hydroehlorothiazide combim tion on ambulatory blood pressure and cognitive function elderly hypertensive patients [J]. J Hum Hypertens, 2006, (3) :177-185.
  • 7Biessels GJ,Gispen WH. The impact of diabetes on cognition: What can be learned from rodent models? [J]. Neurobiol Aging,2005,26(Supp 1 ) :36-41.
  • 8Artola A, Kamal A, Ramakers GM, et al. Diabetes mellitus concomitantly facilitates the induction of long term depression and inhibits that of long-term potentiation in hippocampus[J]. Eur J Neurosci, 2005,22 ( 1 ) : 169-178.
  • 9Cowley MA, Smith RG, Diano S, et al. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis[J]. Neuron, 2003,37(4) : 649-661.
  • 10Yajun Liu, Paulus SW, Dongping Xie, et al. Ghrelin Reduces Injury of Hippocampal Neurons in a Rat Model of Cerebral Ischemia/Reperfusion[J]. Chinese Journal of Physiology, 2006, 49(5) : 244-250.

共引文献12

同被引文献31

  • 1钟远,贾伟平.中老年2型糖尿病早期认知功能改变的临床研究[J].实用诊断与治疗杂志,2005,19(8):581-583. 被引量:27
  • 2陆再英,钟南山.内科学[M].第7版.北京:人民卫生出版社.2008:251.
  • 3Schmidt MI, Hadji-Georgopoulos A, Rendell M,et al. Thedawn phenomenon, an early morning glucose rise : implicationsfor diabetic intraday blood glucose variation [ J]. DiabetesCare,1981,4(6) ;579-585.
  • 4Sung JY,Park SB,Liu YT,et al. Progressive axonal dysfunc-tion precedes development of neuropathy in type 2 diabetes[J]. Diabetes,2012,61 (6) :1592-1598.
  • 5Rybicka M,Krysiak R,Okopien B. The dawn phenomenon andthe Somogyi effect-two phenomena of morning hyperglycae-mia [Jj.Endokrynol Pol,2011,62(3) :276-284.
  • 6Biessels G J, Deary I J, Ryan C M. Cognition and diabetes: a lifespan perspective[J]. Lancet Neurol, 2008,7 (2) : 184-190.
  • 7van den Berg E, Kloppenborg R P, Kessels R P, et al. Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: a systematic comparison of their impact on cognition[J]. Biochim Biophys Acta,2009,1792(5) :470-481.
  • 8Zemva J, Schubert M. Central insulin and insulin-like growth factor-1 signaling: implications for diabetes associated dementia [J]. Curr Diabetes Rev,2011,7(5) :356-366.
  • 9Petersen R C, Smith G E, Waring S C, et al. Mild cognitive impairment: clinical characterization and outcome [J]. Arch Neurol, 1999,56(3) :303-308.
  • 10Nouwen A, Winkley K, Twisk J, et al. Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis[J]. Diabetologia, 2010,53 ( 12 ) : 2480- 2486.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部